Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)
·MeSH: Acquired angioedema
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| deucrictibant | Pharvaris N.V. (PHVS) |
Frequently asked questions
How many drugs are in development for Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)?
BioSniper tracks 1 drug in development for Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH) across 1 company.
How many clinical trials target Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)?
There are 1 clinical trial targeting Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH) tracked by BioSniper.
Deep-dive into Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis